H.C. Wainwright Reiterates Buy Rating on BioNTech (BNTX)

August 19, 2024 6:48 AM UTC Send to a Friend
H.C. Wainwright analyst Raghuram Selvaraju reiterated a Buy rating and $113.00 price target on BioNTech (NASDAQ: BNTX)The analyst commented: "Late ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login